Serge Picaud

Scientific Advisor at GenSight Biologics

Serge Picaud is director of research at the Vision Institute in Paris. Over the last 15 years, he has developed many cellular and animal models of different retinal diseases for assessing the efficacy of neuroprotection or other therapeutic strategies. He thus developed the culture of post-mortem human retinal tissue, which provides the means to test AAV vectors efficacy on human retinal neurones.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


GenSight Biologics

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.


Headquarters

Paris, France

Employees

11-50

Links